Abstract
Background and Objective: Chrysin and its derivatives proved to possess potential anti-tumour activity.
Materials and Methods: A new series of chrysin analogs containing 1,2,3-triazoles with different substituent groups (5a-5l) was designed, synthesized, and evaluated as potential anticancer agents. The synthesized compounds were characterized using FT-IR, 1H NMR 13C NMR spectroscopy and mass spectrometry.
Results: The anticancer activities of the synthesized compounds were studied in four cancer cell lines viz. PC3, PC3-PSMA, MCF-7 and UM-UC-3 using doxorubicin as standard. Among all the tested compounds, 5c was found as most active with IC50 value of 10.8 ± 0.04 μM in PC3 cells and 20.53 ± 0.21 μMin MCF-7 cells, respectively. Flow cytometry analyses indicated that synthesized compounds 5a, 5c, and 5h arrested MCF-7 cells at the G2/M phase in a dose-dependent manner.
Conclusion: Chyrsin derivatives could be novel anticancer agents.
Keywords: Chrysin, triazoles, anticancer activity, drug design, QSAR, cell cycle analysis.
Graphical Abstract
[http://dx.doi.org/10.3322/caac.20107] [PMID: 21296855]
[http://dx.doi.org/10.1126/science.287.5460.1960] [PMID: 10720314]
[http://dx.doi.org/10.1021/cr900019j] [PMID: 19422222]
[http://dx.doi.org/10.1021/np068054v.] [PMID: 17309302]
[http://dx.doi.org/10.1016/j.drudis.2015.01.009] [PMID: 25617672]
[http://dx.doi.org/10.1021/acs. jnatprod.5b01055.]
[http://dx.doi.org/10.1016/S0955-2863(02)00208-5] [PMID: 12550068]
[http://dx.doi.org/10.2174/187152809788681029.] [PMID: 19601883. ]
[http://dx.doi.org/10.1007/s13205-013-0117-5] [PMID: 28324424]
[PMID: 16097445]
[http://dx.doi.org/10.1080/14786419.2013.790027.] [PMID: 23651316]
[http://dx.doi.org/10.1007/s00044-015-1396-7]
[http://dx.doi.org/10.4062/biomolther.2015.095] [PMID: 26336587]
[http://dx.doi.org/10.1016/j.taap.2011.04.008.] [PMID: 21515303]
[http://dx.doi.org/10.1111/j.1365-2672.2011.05170.x] [PMID: 21972890]
[http://dx.doi.org/10.1211/jpp.61.06.0015] [PMID: 19505373]
[http://dx.doi.org/10.1016/j.ejmech.2013.12.044] [PMID: 24556144]
[http://dx.doi.org/10.1007/s00044-014-1267-7]
[http://dx.doi.org/10.1016/j.bmcl.2015.10.052] [PMID: 26514745]
[http://dx.doi.org/10.1016/j.ejps.2016.02.011] [PMID: 26924226]
[http://dx.doi.org/10.4103/2231-0738.106993]
[http://dx.doi.org/10.1016/j.cbi.2007.08.007] [PMID: 17884029]
[http://dx.doi.org/10.1016/j.ejpb.2014.03.011] [PMID: 24691159]
[http://dx.doi.org/10.1016/j.ejmech.2016.08.039] [PMID: 27598238]
[http://dx.doi.org/10.2174/092986707781058805.] [PMID: 17627520]
[http://dx.doi.org/10.1016/j.ejmech.2014.02.029] [PMID: 24583605]
[http://dx.doi.org/10.1016/j.bmcl.2013.03.086] [PMID: 23623419]
[http://dx.doi.org/10.1007/s00044-013-0882-z]
[http://dx.doi.org/10.1016/j.ejmech.2013.04.045]
bDürüst, Y.; Karakuş, H.; Kaiser, M.; Tasdemir, D. Synthesis and anti-protozoal activity of novel dihydropyrrolo[3,4-d][1,2,3]triazoles. Eur. J. Med. Chem., 2012, 48, 296-304.
[http://dx.doi.org/10.1016/j.ejmech.2011.12.028] [PMID: 22217867]
[http://dx.doi.org/10.1016/j.ejmech.2014.07.042] [PMID: 25038485]
[http://dx.doi.org/10.1016/j.ejmech.2014.06.049] [PMID: 24983538]
[http://dx.doi.org/10.3797/scipharm.1302-04] [PMID: 24106665]
[http://dx.doi.org/10.1016/j.ejmech.2012.12.025] [PMID: 23314049]
[http://dx.doi.org/10.1016/j.colsurfb.2016.06.028] [PMID: 27472455]